Showing 1,101 - 1,120 results of 54,608 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 100 ((teer decrease) OR (a decrease)) ))', query time: 0.90s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104

    GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

    Published 2017
    “…(<b>C,E</b>) The composite glutamate (in the presence of 100 μM glycine) concentration-response curves reveal a significant decrease in glutamate potency in both di-heteromeric (<b>C</b>) and tri-heteromeric (<b>E</b>) GluN2A(D731N)-containing NMDARs compared to wild type receptors. …”
  5. 1105
  6. 1106
  7. 1107
  8. 1108
  9. 1109
  10. 1110
  11. 1111
  12. 1112
  13. 1113

    Data_Sheet_1_Molecular Mechanisms by Which S100A4 Regulates the Migration and Invasion of PGCCs With Their Daughter Cells in Human Colorectal Cancer.zip by Fei Fei (794241)

    Published 2020
    “…The tumorigenic and metastatic ability of PGCCs with their daughter cells in vivo was significantly stronger compared to the untreated cells, which was significantly decreased after S100A4 knockdown. Moreover, the expression of S100A4-related proteins was positively correlated with the malignancy degree of human CRC, and maintained a high level in lymph node metastasis. …”
  14. 1114

    GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

    Published 2017
    “…Di-heteromeric (h2A-D731N), one-copy and two-copy mutant tri-heteromeric (D731N/2A and D731N/D731N) receptors show a decreased current ratio, indicating enhanced proton sensitivity. …”
  15. 1115
  16. 1116
  17. 1117
  18. 1118
  19. 1119

    <i>WDR5</i> Expression Is Prognostic of Breast Cancer Outcome by Xiaofeng Dai (793874)

    Published 2015
    “…Given the similarities between breast and prostate cancers, we explore the potential prognostic value of <i>WDR5</i> gene expression on breast cancer survival. …”
  20. 1120